Načítá se...
A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells
The treatment of patients with invasive breast cancer remains a major issue because of the acquisition of drug resistance to conventional chemotherapy. Here we propose a new therapeutic strategy by combining DNA methyltransferase inhibitors (DMTIs) with suramin. Cytotoxic effects of suramin or combi...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3982927/ https://ncbi.nlm.nih.gov/pubmed/24510012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2857-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|